Genomic Justice and Imagined Communities

Area of Science:

• Bioethics
• Genomic Medicine
• Health Policy

Background:

• National biobanking efforts, like the U.S. Precision Medicine Initiative (PMI), establish "imagined genetic communities."
• The PMI aims to recruit diverse donor-partners, reflecting the U.S. population's racial and ethnic diversity.
• Debates surrounding genomic medicine, informed consent, and benefit sharing are influenced by justice considerations.

Purpose of the Study:

• To explore the assumptions about community embedded within the U.S. Precision Medicine Initiative.
• To critically examine the potential for public-private partnerships in biobanking to exacerbate existing inequalities.
• To analyze the historical and global implications of imagined genetic communities in genomic research.

Main Methods:

• Qualitative analysis of policy documents and ethical debates.
• Review of historical cases, including the Icelandic deCODE genomic biobank and its influence on Mexican policy.
• Exploration of ethical frameworks concerning justice in genomic medicine.

Main Results:

• The PMI's concept of an "imagined genetic community" requires critical attention.
• Public-private partnerships central to the PMI could widen health disparities.
• Historical examples demonstrate the significant economic and political implications of genetic biobanks.

Conclusions:

• Genomic medicine initiatives must address the ethical implications of "imagined genetic communities."
• Careful consideration of justice and equity is crucial in the design and implementation of national biobanking efforts.
• The potential for market-based colonialism necessitates proactive policy development in global health.
• The U.S. Precision Medicine Initiative must navigate the complexities of community, diversity, and equity to avoid perpetuating inequalities.